Metformin-enhances resilience via hormesis

Ageing Res Rev. 2021 Nov:71:101418. doi: 10.1016/j.arr.2021.101418. Epub 2021 Aug 5.

Abstract

The present paper demonstrates that metformin (MF) induced a broad spectrum of hormetic biphasic dose responses in a wide range of experimental studies, affecting multiple organ systems, cell types, and endpoints enhancing resilience to chemical stresses in preconditioning and co-current exposure protocols. Detailed mechanistic evaluations indicate that MF-induced hormetic-adaptive responses are mediated often via the activation of adenosine monophosphate-activated kinase (AMPK) protein and its subsequent upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2). Hormesis-induced protective responses by MF are largely mediated via a vast and highly integrated anti-inflammatory molecular network that enhances longevity and delays the onset and slows the progression of neurodegenerative and other chronic diseases.

Keywords: AMPK; Aging; Hormesis; Metformin; Neuroprotection; Nrf2.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Hormesis*
  • Longevity
  • Metformin* / pharmacology

Substances

  • Metformin